Valuation: Seegene, Inc.

Market Cap 1,287B 852M 747M 690M 637M 1.21B 81.57B 1.23B 8.29B 3.22B 39.92B 3.2B 3.13B 139B P/E 2026 *
16x
P/E 2027 * 13.6x
Enterprise Value 1,287B 852M 747M 690M 637M 1.21B 81.57B 1.23B 8.29B 3.22B 39.92B 3.2B 3.13B 139B EV / Sales 2026 *
2.42x
EV / Sales 2027 * 2.13x
Free-Float
59.55%
Yield 2026 *
3.89%
Yield 2027 * 4.21%
1 day-3.58%
1 week-1.57%
Current month-4.88%
1 month+3.29%
3 months+23.90%
6 months+20.73%
Current year+18.70%
1 week 27,800
Extreme 27800
30,500
1 month 26,350
Extreme 26350
31,450
Current year 21,700
Extreme 21700
32,500
1 year 21,700
Extreme 21700
33,050
3 years 19,040
Extreme 19040
36,650
5 years 19,040
Extreme 19040
90,800
10 years 7,225
Extreme 7225
161,100
Manager TitleAgeSince
Chief Executive Officer 69 2010-09-16
President 54 -
President 74 -
Director TitleAgeSince
Director/Board Member 69 2011-06-30
Chairman 79 -
Director/Board Member 74 -
Date Insider Type Main position Quantity % Market Cap.
24-05-29Sell

Executive/Senior Manager

4,201 0.0080%
24-05-29Sell

Executive/Senior Manager

191 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-3.58%-1.57%-9.16%+45.39% 881M
-0.07%-6.23%+111.14%+136.69% 4.48B
-3.17%-9.88%+71.72%+233.77% 3.33B
-0.95%-6.92%-30.75%-41.82% 1.96B
-1.61%+7.81%+141.81%-40.88% 1.94B
-2.68%-5.81%+43.12%+173.04% 1.46B
-2.70%-6.34%+108.70%-52.71% 873M
-8.72%-15.59%-5.65% - 488M
-1.61%-0.96%-36.68%-17.99% 487M
-6.81%-20.51% - - 182M
Average -3.19%-4.30%+43.80%+54.44% 1.61B
Weighted average by Cap. -1.96%-3.31%+68.00%+95.26%

Financials

2026 *2027 *
Net sales 531B 351M 308M 285M 263M 498M 33.65B 508M 3.42B 1.33B 16.47B 1.32B 1.29B 57.16B 603B 399M 350M 323M 299M 566M 38.24B 578M 3.89B 1.51B 18.71B 1.5B 1.47B 64.95B
Net income 92.2B 61.03M 53.53M 49.42M 45.67M 86.56M 5.84B 88.29M 594M 231M 2.86B 229M 224M 9.93B 108B 71.69M 62.88M 58.05M 53.64M 102M 6.86B 104M 698M 271M 3.36B 269M 263M 11.66B
Net Debt - -
Logo Seegene, Inc.
Seegene Inc is a Korea-based company engaged in the development, manufacturing and distribution of molecular diagnostic reagents. The Company mainly provides infectious pathogens inspection products, including allergic respiratory pathogens, sexually transmitted diseases pathogens, human papilloma virus (HPV) and other inspection products, drug resistance inspection products, single nucleotide polymorphisms (SNP) inspection products, as well as somatic mutation cancer inspection products. In addition, it is involved in the provision of automatic real-time detection instruments. The Company provides its products under the brand names of Seeplex, Anyplex and Magicplex. The Company distributes its products within domestic market and to overseas markets.
Employees
216
Date Price Change Volume
26-07-08 ₩28,250.00 -3.58% 246,042
26-07-07 ₩29,300.00 +0.86% 235,033
26-07-06 ₩29,050.00 -1.02% 212,640
26-07-03 ₩29,350.00 +1.38% 294,822
26-07-02 ₩28,950.00 +0.87% 166,162
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
28,250.00KRW
Average target price
39,500.00KRW
Spread / Average Target
+39.82%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A096530 Stock